PTK2 and urinary bladder cancer: Collectively, our data delineate a COL1A2-driven signaling axis wherein ECM remodeling activates integrin-FAK signaling cascades, thereby facilitating the transition from non–muscle-invasive to muscle-invasive bladder cancer.